ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 243 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $51,281,000 | -10.1% | 551,745 | -42.4% | 0.01% | -18.2% |
| Q3 2021 | $57,031,000 | -11.9% | 957,698 | +0.9% | 0.01% | -15.4% |
| Q2 2021 | $64,746,000 | -0.5% | 949,366 | +1.3% | 0.01% | 0.0% |
| Q1 2021 | $65,058,000 | -6.3% | 937,591 | +3.7% | 0.01% | -13.3% |
| Q4 2020 | $69,451,000 | +19.8% | 903,961 | +16.6% | 0.02% | +7.1% |
| Q3 2020 | $57,982,000 | +18.6% | 775,253 | -0.1% | 0.01% | +7.7% |
| Q2 2020 | $48,869,000 | +169.5% | 776,320 | +79.8% | 0.01% | +116.7% |
| Q1 2020 | $18,135,000 | +78.4% | 431,823 | +93.0% | 0.01% | +100.0% |
| Q4 2019 | $10,164,000 | +3.0% | 223,786 | +3.8% | 0.00% | 0.0% |
| Q3 2019 | $9,867,000 | -26.6% | 215,587 | -6.0% | 0.00% | -25.0% |
| Q2 2019 | $13,445,000 | +38.6% | 229,307 | +6.0% | 0.00% | +33.3% |
| Q1 2019 | $9,699,000 | -2.1% | 216,346 | -15.0% | 0.00% | 0.0% |
| Q4 2018 | $9,909,000 | -1.5% | 254,426 | +16.4% | 0.00% | 0.0% |
| Q3 2018 | $10,063,000 | -5.0% | 218,670 | -10.0% | 0.00% | 0.0% |
| Q2 2018 | $10,594,000 | +19.0% | 243,007 | +7.8% | 0.00% | +50.0% |
| Q1 2018 | $8,905,000 | +55.6% | 225,466 | +33.8% | 0.00% | 0.0% |
| Q4 2017 | $5,724,000 | +31.8% | 168,537 | -1.1% | 0.00% | +100.0% |
| Q3 2017 | $4,343,000 | +84.3% | 170,336 | +22.0% | 0.00% | 0.0% |
| Q2 2017 | $2,356,000 | – | 139,676 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |
| IFP Advisors, Inc | 2 | $1,000 | 0.00% |